N-Hydroxy-MDA Hydrochloride
- CAS No.
- 74341-83-6
- Chemical Name:
- N-Hydroxy-MDA Hydrochloride
- Synonyms
- N-Hydroxy-MDA Hydrochloride;N-hydroxy MDA (hydrochloride) (exempt preparation)
- CBNumber:
- CB12700686
- Molecular Formula:
- C10H14ClNO3
- Molecular Weight:
- 231.67606
- MDL Number:
- MFCD00171386
- MOL File:
- 74341-83-6.mol
- MSDS File:
- SDS
| solubility |
DMF: 10 mg/ml DMSO: 10 mg/ml Ethanol: 15 mg/mlPBS (pH 7.2): 5 mg/ml |
|---|---|
| FDA UNII | R0H604RFC0 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS06 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H330-H310-H300 | |||||||||
| Precautionary statements | P264-P270-P301+P310-P321-P330-P405-P501-P260-P271-P284-P304+P340-P310-P320-P403+P233-P405-P501-P262-P264-P270-P280-P302+P350-P310-P322-P361-P363-P405-P501 | |||||||||
| NFPA 704 |
|
N-Hydroxy-MDA Hydrochloride price More Price(5)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 13958 | N-hydroxy MDA (hydrochloride) ≥95% | 74341-83-6 | 5mg | $41 | 2026-04-30 | Buy |
| Cayman Chemical | 15688 | N-hydroxy MDA (hydrochloride) (exempt preparation) ≥95% | 74341-83-6 | 1mg | $69 | 2026-04-30 | Buy |
| Cayman Chemical | 13958 | N-hydroxy MDA (hydrochloride) ≥95% | 74341-83-6 | 10mg | $75 | 2026-04-30 | Buy |
| Cayman Chemical | 13958 | N-hydroxy MDA (hydrochloride) ≥95% | 74341-83-6 | 50mg | $312 | 2026-04-30 | Buy |
| American Custom Chemicals Corporation | CHM0293115 | N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE HYDROCHLORIDE 95.00% | 74341-83-6 | 5MG | $495.94 | 2021-12-16 | Buy |
N-Hydroxy-MDA Hydrochloride Chemical Properties, Uses, Production
Description
3,4-
Uses
N-Hydroxy-MDA is an 3,4-methylenedioxymethamphetamine (M303985) analogue and was studied as a inhibitor of [3H]noradrenaline and [3H]5-HT transport in mammalian cell lines.
References
[1] T MONTGOMERY. Comparative potencies of 3,4-methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell lines[J]. British Journal of Pharmacology, 2009, 152 7: 1121-1130. DOI: 10.1038/sj.bjp.0707473
[2] MATTHEW J BAGGOTT. Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans.[J]. ACS Applied Bio Materials, 2010: e14074. DOI: 10.1371/journal.pone.0014074





